Dataset from A Phase 3, Double-blind, Randomized, Multi-center, Placebo Controlled, Dose-optimization Study Evaluating the Safety, Efficacy, and Tolerability of Once Daily Dosing With Extended-release Guanfacine Hydrochloride in Adolescents Aged 13-17 Years Diagnosed With Attention-deficit/Hyperactivity Disorder (ADHD)
收藏NIAID Data Ecosystem2026-05-10 收录
下载链接：
https://doi.org/10.25934/PR00008007
下载链接
链接失效反馈官方服务：
资源简介：
To assess the efficacy of optimized Extended-release Guanfacine Hydrochloride compared with
placebo in the treatment of adolescents aged 13-17 years with a diagnosis of ADHD as measured
by the ADHD-RS-IV
创建时间：
2026-03-25
